Compounds > cyclosporine

cyclosporine and Chromosome Deletion

cyclosporine has been researched along with Chromosome Deletion in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balleari, E; Bernal, T; Beyne-Rauzy, O; Bordessoule, D; Calabuig, M; Cametti, G; Campelo, MD; Cheze, S; Cony-Makhoul, P; Dreyfus, F; Fenaux, P; Fensterl, J; Ferrero, D; Gaidano, G; Germing, U; Gioia, D; Götze, K; Guerci-Bresler, A; Hamel, JF; Kaivers, J; Kelaidi, C; Komrokji, R; Kotsianidis, I; Müller-Thomas, C; Pane, F; Park, S; Ramos, F; Roboz, GJ; Rose, C; Sanna, A; Santini, V; Sanz, GF; Sapena, R; Sekeres, MA; Stamatoullas, A; Steensma, DP; Thépot, S; Toma, A; Vey, N; Wattel, E1
Hama, A; Ito, E; Ito, M; Kobayashi, R; Kojima, S; Kosaka, Y; Muramatsu, H; Narita, A; Ohara, A; Ohga, S; Takahashi, Y; Tsuchida, M; Yabe, H1
Au, WY; Chan, GC; Ha, SY; Hon, C; Ma, SK; Wong, KF1
Ando, M; Oshimi, K; Sugimoto, K; Tamayose, K1
Kincaid, RL; O'Keefe, SJ; O'Neill, EA; Tamura, J; Tocci, MJ1
Brown, DA; Diamond, DJ; Kondo, KL; Wong, SW1
Brizuela, L; Dumont, FJ; Parent, SA; Siekierka, JJ; Sigal, NH; Wiederrecht, G1

Reviews

1 review(s) available for cyclosporine and Chromosome Deletion

ArticleYear
Is FKBP involved in the immunosuppressive and/or toxic mechanism of action of FK 506?
    Transplantation proceedings, 1991, Volume: 23, Issue:6

    Topics: Amino Acid Isomerases; Animals; Carrier Proteins; Chromosome Deletion; Cyclosporine; Humans; Immunosuppressive Agents; Neurospora crassa; Peptidylprolyl Isomerase; Saccharomyces cerevisiae; Tacrolimus; Tacrolimus Binding Proteins

1991

Trials

1 trial(s) available for cyclosporine and Chromosome Deletion

ArticleYear
Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine.
    Haematologica, 2015, Volume: 100, Issue:11

    Topics: Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 7; Cyclosporine; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Infant; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Prospective Studies

2015

Other Studies

5 other study(ies) available for cyclosporine and Chromosome Deletion

ArticleYear
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, May-10, Volume: 35, Issue:14

    Topics: Aged; Aged, 80 and over; Anemia; Antilymphocyte Serum; Antineoplastic Agents; Arsenic; Azacitidine; Chromosome Deletion; Chromosomes, Human, Pair 5; Cyclosporine; Cytarabine; Decitabine; Disease Progression; Enzyme Inhibitors; Erythrocyte Transfusion; Female; Hematinics; Humans; Hydroxyurea; Immunologic Factors; Lenalidomide; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Recurrence; Retreatment; Retrospective Studies; Risk Factors; Survival Rate; Thalidomide; Treatment Failure; Tretinoin; Valproic Acid

2017
Bone marrow transplantation for therapy-related acute myeloid leukemia in congenital retinoblastoma associated with 13q deletion syndrome.
    Annals of hematology, 2004, Volume: 83, Issue:7

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosome Deletion; Chromosomes, Human, Pair 13; Cryosurgery; Cryotherapy; Cyclosporine; DNA-Binding Proteins; Enzyme Inhibitors; Eye Neoplasms; Female; Histone-Lysine N-Methyltransferase; Humans; Infant, Newborn; Leukemia, Myeloid; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Peripheral Blood Stem Cell Transplantation; Proto-Oncogenes; Remission Induction; Retinoblastoma; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Vincristine

2004
Disappearance of chromosomal abnormalities and recovery of hematopoiesis after immunosuppressive therapy for hypoplastic refractory anemia with excess of blasts.
    Blood, 2001, Apr-15, Volume: 97, Issue:8

    Topics: Anemia, Refractory, with Excess of Blasts; Antilymphocyte Serum; Chromosome Aberrations; Chromosome Deletion; Chromosomes, Human, Pair 8; Cyclosporine; Hematopoiesis; Humans; Immunosuppressive Agents; Karyotyping; Male; Middle Aged; Remission Induction; T-Lymphocytes; Trisomy

2001
FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin.
    Nature, 1992, Jun-25, Volume: 357, Issue:6380

    Topics: Animals; Calcineurin; Calmodulin-Binding Proteins; Cell Line; Chloramphenicol O-Acetyltransferase; Chromosome Deletion; Cyclosporine; Gene Expression Regulation; Humans; Interleukin-2; Ionomycin; Kinetics; Macromolecular Substances; Mice; Phosphoprotein Phosphatases; Polymerase Chain Reaction; Promoter Regions, Genetic; Recombinant Proteins; Tacrolimus; Tetradecanoylphorbol Acetate; Transcription, Genetic; Transfection

1992
Characterization of nuclear protein binding to the interferon-gamma promoter in quiescent and activated human T cells.
    European journal of immunology, 1992, Volume: 22, Issue:9

    Topics: Base Sequence; Binding, Competitive; Cell Nucleus; Chromosome Deletion; Cyclosporine; DNA; Humans; Interferon-gamma; Lymphocyte Activation; Molecular Sequence Data; Mutagenesis; Nuclear Proteins; Organ Specificity; Phytohemagglutinins; Promoter Regions, Genetic; Protein Binding; T-Lymphocytes; Tetradecanoylphorbol Acetate

1992